May 28, 2020 Bio/Pharma/CRO Clinical Research/Diagn. Microscopy

Roche initiates phase III clinical trial of Actemra/RoActemra plus remdesivir in hospitalised patients with severe COVID-19 pneumonia

Basel, 28 May 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the initiation of a global phase III, randomised, double-blind, multicentre study (REMDACTA) to evaluate the safety and efficacy of Actemra/RoActemra plus the investigational antiviral remdesivir, versus placebo plus remdesivir in hospitalised patients with severe COVID-19 pneumonia, in collaboration with Gilead Sciences, Inc.  Read more

May 26, 2020 Clinical Research/Diagn. Life Science Tools Product Launch

Leica Biosystems and Bio-Techne Announce European Launch of the CE-IVD RNAscope in Situ Hybridization Detection Kit

MAY 26, 2020 The CE-IVD marked system will enable diagnostic pathologists with new applications MINNEAPOLIS, May 26, 2020 /PRNewswire/ — Bio-Techne (NASDAQ:TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities and Leica Biosystems, a global leader in workflow solutions and automation, are proud to announce... Read more

May 22, 2020 Clinical Research/Diagn. Life Science Tools M&A, Partnerships

Roche acquires Stratos Genomics to further develop DNA based sequencing for diagnostic use

Genomics insights generated through sequencing an individual’s DNA play a critical role in personalised healthcare and clinical diagnostics of the future Roche is committed to developing a nanopore sequencer with the aim of providing the healthcare community and ultimately patients with faster and more accurate medical information to predict risk and detect disease This investment... Read more

May 14, 2020 Clinical Research/Diagn. Informatics & Software PR/Corporate

Clear Labs Raises $18M; Plans to Expand Application of Automated Next-Generation Sequencing Platform to COVID-19 Diagnostics

Company’s novel characterizing diagnostic could significantly improve testing rates, results, and ability to trace the virus MENLO PARK, CALIF. (PRWEB) MAY 14, 2020 Clear Labs, providers of the only automated and intelligent diagnostic NGS platform, today announced the raise of a $18M strategic round of funding led by Redmile Group, as well as existing investors including... Read more

May 14, 2020 Clinical Research/Diagn. PAI Top-10

Roche to present first clinical data on novel anti-TIGIT cancer immunotherapy tiragolumab at ASCO

Phase II CITYSCAPE trial shows promising results adding tiragolumab to Tecentriq in people with PD-L1-positive metastatic non-small cell lung cancer Full results will be presented in an oral abstract session at the ASCO20 Virtual Scientific Program organised by the American Society of Clinical Oncology (ASCO) Basel, 14 May 2020 – Roche (SIX: RO, ROG; OTCQX:... Read more

May 12, 2020 Acad, Gov/Utilities Clinical Research/Diagn. Lab Top-10 Liq. Handling & Robotics

FDA Further Expands EUA for Thermo Fisher Scientific's COVID-19 Diagnostic Tests

Authorization brings more instruments on line, enables workflow flexibility and simplifies methods to increase throughput and allow more labs to run tests WALTHAM, Mass., May 12, 2020 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that the U.S. Food and Drug Administration (FDA) has further expanded emergency... Read more

May 12, 2020 Clinical Research/Diagn. Licensing, IP, and Legal Life Science Tools

Zymo Research Obtains Emergency Use Authorization from FDA for Their Quick SARS-CoV-2 rRT-PCR Kit

Qualitative Test for the Detection of Nucleic Acid From SARS-CoV-2 IRVINE, Calif., (May 12, 2020) — Zymo Research announced today that the US Food and Drug Administration (FDA) has approved its Quick SARS-CoV-2 rRT-PCR Kit (R3011) for Emergency Use Authorization (EUA) for the detection of SARS-CoV-2, the virus that causes COVID-19. The kit is a qualitative test for the... Read more

May 5, 2020 Clinical Research/Diagn. Life Science Tools Product Launch

Swift Biosciences Launches High Throughput NGS Panel for Novel Coronavirus

ANN ARBOR, Mich., May 5, 2020 /PRNewswire/ — Swift Biosciences, Inc., a leader in commercialization of DNA and RNA library preparation kits for Next-Generation Sequencing (NGS), announced the release of its Swift Amplicon SARS-CoV-2 Research Panel. Targeting the full viral genome in a single reaction with a rapid 2-hour workflow, Swift’s assay meets research and surveillance needs... Read more

May 5, 2020 Clinical Research/Diagn. Liq. Handling & Robotics Product Launch

Neutec aids in the fight against COVID19 with automated tube fillers

Caption: Tube and Bottle Filler for COVID-19. Click here to view video. Farmingdale, NY (May 5, 2020) – As more and more laboratories are coming online to combat COVID19, Neutec Group has been able to support the effort by providing laboratory automation enabling the necessary large-scale output required for testing. Neutec Group’s tube and bottle fillers have been... Read more

May 4, 2020 Clinical Research/Diagn. Life Science Tools

Bio-Rad Receives FDA Emergency Use Authorization for Droplet Digital PCR SARS-CoV-2 Test Kit

Date: 05/04/2020 HERCULES, Calif. –Bio-Rad Laboratories Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its SARS-CoV-2 Droplet Digital PCR (ddPCR) test kit has been granted Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA). The SARS-CoV-2 Droplet Digital PCR (ddPCR) test runs... Read more